Author:
Appels Natalie M. G. M.,Bolijn Maria J.,van Eijndhoven Maria A. J.,Stephens Trevor C.,Beijnen Jos H.,Schellens Jan H. M.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference24 articles.
1. Bos JL (1989) Ras oncogenes in human cancer: a review. Cancer Res 49(17):4682–4689
2. Kato K, Cox AD, Hisaka MM, Graham SM, Buss JE, Der CJ (1992) Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity. Proc Natl Acad Sci USA 89(14):6403–6407
3. Whyte DB, Kirschmeier P, Hockenberry TN, Nunez-Oliva I, James L, Catino JJ, Bishop WR, Pai JK (1997) K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors. J Biol Chem 272(22):14459–14464
4. Kohl NE, Conner MW, Gibbs JB, Graham SL, Hartman GD, Oliff A (1995) Development of inhibitors of protein farnesylation as potential chemotherapeutic agents. J Cell Biochem Suppl 22:145–150
5. Brunner TB, Hahn SM, Gupta AK, Muschel RJ, McKenna WG, Bernhard EJ (2003) Farnesyltransferase inhibitors: an overview of the results of preclinical and clinical investigations. Cancer Res 63(18):5656–5668
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献